Sterol lipidomics in health and disease: Methodologies and applications

European Journal of Lipid Science and Technology

Volumn 111, Issue 1, 2009, Pages 14-38

  Griffiths, William J ^a   Wang, Yuqin ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Bile acids; Liquid chromatography mass spectrometry; Oxysterols; Tandem mass spectrometry

Indexed keywords

EID: 58949084969     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200800116     Document Type: Review

References (175)

1. I. Tabas: Cholesterol in health and disease. J Clin Invest. 2002, 110, 583-90.
2. J. Sjövall: Fifty years with bile acids and steroids in health and disease. Lipids. 2004, 39, 703-722.
3. W. J. Griffiths, K. Karu, M. Hornshaw, G. Woffendin, Y. Wang: Metabolomics and metabolite profiling: past heroes and future developments. Eur J Mass Spectrom (Chichester, Eng). 2007, 13, 45-50.
4. J. H. Beynon: Mass spectrometry and its applications to organic chemistry. Elsevier, Amsterdam (Netherlands) 1960.
5. R. Ryhage, E. Stenhagen: Mass spectrometry in lipid research. J Lipid Res. 1960, 1, 361-390.
6. W. J. Griffiths: Metabolomics, Metabonomics and Metabolite Profiling. Royal Society of Chemistry, Cambridge (UK) 2008.
7. M. Lagarde, A. Géloën, M. Record, D. Vance, F. Spener: Lipidomics is emerging. Biochim Biophys Acta. 2003, 1634, 61.
8. W. J. VandenHeuvel, C. C. Sweeley, E. C. Horning: Separation of steroids by gas chromatography. J Am Chem Soc. 1960, 82, 3481-3482.
9. E. C. Horning: Gas phase analytical methods for the study of steroid hormones and their metabolites. In Gas Phase Chromatography of Steroids. Eds. K. B. Eik-Nes, E. C. Horning, Springer Verlag, Berlin (Germany) 1968, pp. 1-71.
10. P. Back, J. Sjövall, K. Sjövall: Monohydroxy bile acids in plasma in intrahepatic cholestasis of pregnancy. Identification by computerized gas chromatography-mass spectrometry. Med Biol. 1974, 52, 31-38.
11. B. Almé, A. Bremmelgaard, J. Sjövall, P. Thomassen: Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatography-mass spectrometry. J Lipid Res. 1977, 18, 339-362.
12. A. Bremmelgaard, J. Sjövall: Bile acid profiles in urine of patients with liver diseases. Eur J Clin Invest. 1979, 9, 341-348.
13. J. Sjövall, A. M. Lawson, K. D. Setchell: Mass spectrometry of bile acids. Methods Enzymol. 1985, 111, 63-113.
14. A. M. Lawson, K. D. Setchell: Mass spectrometry of bile acids. In: The Bile Acids. Volume 4: Methods and Applications. Eds. K. D. Setchell, D. Kritchevsky, P. P. Nair, Plenum Press, New York (USA) 1988, pp. 167-268.
15. K. D. Setchell, A. M. Lawson: Bile Acids. In: Mass Spectrometry. Clinical Biochemistry - Principles, Methods, Applications. Ed. A. M. Lawson, Walter de Gruyter, Berlin, New York 1989, pp. 54-125.
16. B. Egestad, P. Pettersson, S. Skrede, J. Sjövall: Fast atom bombardment mass spectrometry in the diagnosis of cerebrotendinous xanthomatosis. Scand J Clin Lab Invest. 1985, 45, 443-446.
17. H. Ichimiya, B. Egestad, H. Nazer, E. S. Baginski, P. T. Clayton, J. Sjövall: Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment. J Lipid Res. 1991, 32, 829-841.
18. P. T. Clayton, J. V. Leonard, A. M. Lawson, K. D. Setchell, S. Andersson, B. Egestad, J. Sjövall: Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids. J Clin Invest. 1987, 79, 1031-1038.
19. J. E. Heubi, K. D. Setchell, K. E. Bove: Inborn errors of bile acid metabolism. Semin Liver Dis. 2007, 27, 282-294.
20. F. D. Porter: Malformation syndromes due to inborn errors of cholesterol synthesis. J Clin Invest. 2002, 110, 715-724.
21. K. Simons, R. Ehehalt: Cholesterol, lipid rafts, and disease. J Clin Invest. 2002, 110, 597-603.
22. A. J. Travis, G. S. Kopf: The role of cholesterol efflux in regulating the fertilization potential of mammalian spermatozoa. J Clin Invest. 2002, 110, 731-736.
23. G. J. Schroepfer Jr: Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev. 2000, 80, 361-554.
24. C. Yang, J. G. McDonald, A. Patel, Y. Zhang, M. Umetani, F. Xu, E. J. Westover, D. F. Covey, D. J. Mangelsdorf, J. C. Cohen, H. H. Hobbs: Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem. 2006, 281, 27816-27826.
25. Y. Wang, K. Karu, W. J. Griffiths: Analysis of neurosterols and neurosteroids by mass spectrometry. Biochimie. 2007, 89, 182-191.
26. S. Dzeletovic, O. Breuer, E. Lund, U. Diczfalusy: Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem. 1995, 225, 73-80.
27. A. Babiker, U. Diczfalusy: Transport of side-chain oxidized oxysterols in the human circulation. Biochim Biophys Acta. 1998, 1392, 333-339.
28. E. G. Lund, U. Diczfalusy: Quantitation of receptor ligands by mass spectrometry. Methods Enzymol. 2003, 364, 24-37.
29. U. Diczfalusy: Analysis of cholesterol oxidation products in biological samples. J AOAC Int. 2004, 87, 467-473.
30. I. Burkard, K. M. Rentsch, A. von Eckardstein: Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. J Lipid Res. 2004, 45, 776-781.
31. J. G. McDonald, B. M. Thompson, E. C. McCrum, D. W. Russell: Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry. Methods Enzymol. 2007, 432, 145-170.
32. K. Karu, M. Hornshaw, G. Woffendin, K. Bodin, M. Hamberg, G. Alvelius, J. Sjövall, J. Turton, Y. Wang, W. J. Griffiths: Liquid chromatography-mass spectrometry utilizing multistage fragmentation for the identification of oxysterols. J Lipid Res. 2007, 48, 976-987.
33. W. J. Griffiths: Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids. Mass Spectrom Rev. 2003, 22, 81-152.
34. K. Blau, G. King: Handbook of Derivatives for Chromatography. Heyden & Son Ltd, London, Philadelphia, Rheine 1979.
35. nd Edition. Wiley, Chichester (UK) 1993.
36. nd edition. Springer (Netherlands) 2008.
37. Y. Wang, W. J. Griffiths: Modern methods of bile acid analysis by mass spectrometry: a view into the metabolome. Curr Anal Chem. 2007, 3, 103-126.
38. J. L. Goldstein, R. A. DeBose-Boyd, M. S. Brown: Protein sensors for membrane sterols. Cell. 2006, 124, 35-46.
39. J. D. Horton, J. L. Goldstein, M. S. Brown: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002, 109, 1125-1131.
40. L. J. Engelking, G. Liang, R. E. Hammer, K. Takaishi, H. Kuriyama, B. M. Evers, W. P. Li, J. D. Horton, J. L. Goldstein, M. S. Brown: Schoenheimer effect explained-feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. J Clin Invest. 2005, 115, 2489-2498.
41. C. Yang, J. G. McDonald, A. Patel, Y. Zhang, M. Umetani, F. Xu, E. J. Westover, D. F. Covey, D. J. Mangelsdorf, J. C. Cohen, H. H. Hobbs: Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem. 2006, 281, 27816-27826.
42. Y. Wang, S. Muneton, J. Sjövall, J. N. Jovanovic, W. J. Griffiths: The Effect of 24S-Hydroxycholesterol on Cholesterol Homeostasis in Neurons: Quantitative Changes to the Cortical Neuron Proteome. J Proteome Res. 2008, 7, 1606-1614.
43. B. A. Janowski, M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, D. J. Mangelsdorf: Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci U S A. 1999, 96, 266-271.
44. C. A. Wassif, J. Yu, J. Cui, F. D. Porter, N. B. Javitt: 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway. Steroids. 2003, 68, 497-502.
45. I. A. Pikuleva: Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos. 2006, 34, 513-520.
46. N. B. Javitt: Oxysterols: functional significance in fetal development and the maintenance of normal retinal function. Curr Opin Lipidol. 2007, 18, 283-288.
47. I. Björkhem, L. Starck, U. Andersson, D. Lütjohann, S. von Bahr, I. Pikuleva, A. Babiker, U. Diczfalusy: Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol. J Lipid Res. 2001, 42, 366-371.
48. X. Fu, J. G. Menke, Y. Chen, G. Zhou, K. L. MacNaul, S. D. Wright, C. P. Sparrow, E. G. Lund: 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem. 2001, 276, 38378-38387.
49. A. Radhakrishnan, Y. Ikeda, K. J. Kwon, M. S. Brown, J. L. Goldstein: Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci U S A. 2007, 104, 6511-6518.
50. B. L. Song, N. B. Javitt, R. A. DeBose-Boyd: Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 2005, 1, 179-189.
51. M. Irons, E. R. Elias, G. Salen, G. S. Tint, A. K. Batta: Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet. 1993, 341, 1414.
52. C. A. Wassif, C. Maslen, S. Kachilele-Linjewile, D. Lin, L. M. Linck, W. E. Connor, R. D. Steiner, F. D. Porter: Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet. 1998, 63, 55-62.
53. G. S. Tint, M. Irons, E. R. Elias, A. K. Batta, R. Frieden, T. S. Chen, G. Salen: Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med. 1994, 330, 107-113.
54. R. I. Kelley: Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta. 1995, 236, 45-58.
55. L. Starck, A. Lövgren: Diagnosis of Smith-Lemli-Opitz syndrome from stored filter paper blood specimens. Arch Dis Child. 2000, 82, 490-492.
56. E. Tierney, N. A. Nwokoro, F. D. Porter, L. S. Freund, J. K. Ghuman, R. I. Kelley: Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet. 2001, 98, 191-200.
57. P. E. Jira, R. A. Wevers, J. de Jong, E. Rubio-Gozalbo, F. S. Janssen-Zijlstra, A. F. van Heyst, R. C. Sengers, J. A. Smeitink: Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome. J Lipid Res. 2000, 41, 1339-1346.
58. N. B. Javitt: Oxysterols: novel biologic roles for the 21st century. Steroids. 2008, 73, 149-157.
59. L. J. Engelking, B. M. Evers, J. A. Richardson, J. L. Goldstein, M. S. Brown, G. Liang: Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin. J Clin Invest. 2006, 116, 2356-2365.
60. P. Clayton, K. Mills, J. Keeling, D. FitzPatrick: Desmosterolosis: a new inborn error of cholesterol biosynthesis. Lancet. 1996, 348, 404.
61. I. Björkhem: Do oxysterols control cholesterol homeostasis? J Clin Invest. 2002, 110, 725-730.
62. M. Axelson, O. Larsson, J. Zhang, J. Shoda, J. Sjövall: Structural specificity in the suppression of HMG-CoA reductase in human fibroblasts by intermediates in bile acid biosynthesis. J Lipid Res. 1995, 36, 290-298.
63. C. Song, S. Liao: Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology. 2000, 141, 4180-4184.
64. L. L. Smith: Cholesterol Autoxidation, Plenum Press, New York (USA) 1981.
65. W. L. Smith, R. C. Murphy: Oxidized lipids formed nonenzymatically by reactive oxygen species. J Biol Chem. 2008; 283, 15513-15514.
66. R. C. Murphy, K. M. Johnson: Cholesterol, reactive oxygen species, and the formation of biologically active mediators. J Biol Chem. 2008, 283, 15521-15525.
67. D. F. Jelinek, S. Andersson, C. A. Slaughter, D. W. Russell: Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem. 1990, 265, 8190-8197.
68. E. G. Lund, J. M. Guileyardo, D. W. Russell: DNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A. 1999, 96, 7238-7243.
69. E. G. Lund, T. A. Kerr, J. Sakai, W. P. Li, D. W. Russell: cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem. 1998, 273, 34316-34327.
70. A. W. Girotti, W. Korytowski: Cholesterol as a singlet oxygen detector in biological systems. Methods Enzymol. 2000, 319, 85-100.
71. K. Wang, E. Bermúdez, W. A. Pryor: The ozonation of cholesterol: separation and identification of 2,4-dinitrophenylhydrazine derivatization products of 3 beta-hydroxy-5-oxo-5,6-secocholestan-6-al. Steroids. 1993, 58, 225-229.
72. M. K. Pulfer, K. Harrison, R. C. Murphy: Direct electrospray tandem mass spectrometry of the unstable hydroperoxy bishemiacetal product derived from cholesterol ozonolysis. J Am Soc Mass Spectrom. 2004, 15, 194-202.
73. M. K. Pulfer, R. C. Murphy: Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J Biol Chem. 2004, 279, 26331-26338.
74. M. K. Pulfer, C. Taube, E. Gelfand, R. C. Murphy: Ozone exposure in vivo and formation of biologically active oxysterols in the lung. J Pharmacol Exp Ther. 2005, 312, 256-264.
75. P. Wentworth Jr, J. Nieva, C. Takeuchi, R. Galve, A. D. Wentworth, R. B. Dilley, G. A. DeLaria, A. Saven, B. M. Babior, K. D. Janda, A. Eschenmoser, R. A. Lerner: Evidence for ozone formation in human atherosclerotic arteries. Science. 2003, 302, 1053-1056.
76. L. L. Smith: Oxygen, oxysterols, ouabain, and ozone: a cautionary tale. Free Radic Biol Med. 2004, 37, 318-324.
77. Q. Zhang, E. T. Powers, J. Nieva, M. E. Huff, M. A. Dendle, J. Bieschke, C. G. Glabe, A. Eschenmoser, P. Wentworth Jr, R. A. Lerner, J. W. Kelly: Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci U S A. 2004, 101, 4752-4757.
78. D. A. Bosco, D. M. Fowler, Q. Zhang, J. Nieva, E. T. Powers, P. Wentworth Jr, R. A. Lerner, J. W. Kelly: Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol. 2006, 2, 249-253.
79. D. W. Russell: The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003, 72, 137-174.
80. I. Björkhem, D. Lütjohann, U. Diczfalusy, L. Ståhle, G. Ahlborg, J. Wahren: Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998, 39, 1594-1600.
81. J. M. Dietschy, S. D. Turley: Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004, 45, 1375-1397.
82. G. Stapleton, M. Steel, M. Richardson, J. O. Mason, K. A. Rose, R. G. Morris, R. Lathe: A novel cytochrome P450 expressed primarily in brain. J Biol Chem. 1995, 270, 29739-29745.
83. J. J. Cali, C. L. Hsieh, U. Francke, D. W. Russell: Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991, 266, 7779-7783.
84. J. Zhang, Y. Akwa, M. el-Etr, E. E. Baulieu, J. Sjövall: Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons. Biochem J. 1997, 322, 175-184.
85. D. Lütjohann, O. Breuer, G. Ahlborg, I. Nennesmo, A. Sidén, U. Diczfalusy, I. Björkhem: Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A. 1996, 93, 9799-9804.
86. J. Li-Hawkins, E. G. Lund, A. D. Bronson, D. W. Russell: Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. J Biol Chem. 2000, 275, 16543-16549.
87. L. J. Meng, W. J. Griffiths, H. Nazer, Y. Yang, J. Sjövall: High levels of (24S)-24-hydroxycholesterol 3-sulfate, 24-glucuronide in the serum and urine of children with severe cholestatic liver disease. J Lipid Res. 1997, 38, 926-934.
88. I. Bjorkhem, U. Andersson, E. Ellis, G. Alvelius, L. Ellegard, U. Diczfalusy, J. Sjovall, C. Einarsson: From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem. 2001, 276, 37004-37010.
89. M. Heverin, S. Meaney, D. Lütjohann, U. Diczfalusy, J. Wahren, I. Björkhem: Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res. 2005, 46, 1047-1052.
90. J. Zhang, Y. Akwa, E. E. Baulieu, J. Sjövall: 7 Alpha-hydroxylation of 27-hydroxycholesterol in rat brain microsomes. C R Acad Sci III. 1995, 318, 345-349.
91. M. Axelson, B. Mörk, J. Sjövall: Occurrence of 3 betahydroxy-5-cholestenoic acid, 3 beta,7 alpha-dihydroxy-5-cholestenoic acid, and 7 alpha-hydroxy-3-oxo-4-cholestenoic acid as normal constituents in human blood. J Lipid Res. 1988, 29, 629-641.
92. W. J. Griffiths, M. Hornshaw, G. Woffendin, S. F. Baker, A. Lockhart, S. Heidelberger, M. Gustafsson, J. Sjövall, Y. Wang: Discovering Oxysterols in Plasma: A Window on the Metabolome. J Proteome Res. 2008, 7, 3602-3612.
93. I. Björkhem: Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006, 260, 493-508.
94. S. Meaney, M. Heverin, U. Panzenboeck, L. Ekström, M. Axelsson, U. Andersson, U. Diczfalusy, I. Pikuleva, J. Wahren, W. Sattler, I. Björkhem: Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid. J Lipid Res. 2007, 48, 944-951.
95. M. S. Brown, J. L. Goldstein: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983, 52, 223-261.
96. J. L. Goldstein, R. G. Anderson, L. M. Buja, S. K. Basu, M. S. Brown: Overloading human aortic smooth muscle cells with low density lipoprotein-cholesteryl esters reproduces features of atherosclerosis in vitro. J Clin Invest. 1977, 59, 1196-1202.
97. J. L. Goldstein, M. S. Brown: Molecular medicine. The cholesterol quartet. Science. 2001, 292, 1310-1312.
98. M. Kivipelto, E. L. Helkala, M. P. Laakso, T. Hänninen, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, A. Nissinen: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001, 322, 1447-1451.
99. A. J. Brown, W. Jessup: Oxysterols and atherosclerosis. Atherosclerosis. 1999, 142, 1-28.
100. I. Björkhem, M. Heverin, V. Leoni, S. Meaney, U. Diczfalusy: Oxysterols and Alzheimer's disease. Acta Neurol Scand Suppl. 2006, 185, 43-49.
101. V. Leoni, T. Masterman, F. S. Mousavi, B. Wretlind, L. O. Wahlund, U. Diczfalusy, J. Hillert, I. Björkhem: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004, 42, 186-191.
102. J. Brown 3rd, C. Theisler, S. Silberman, D. Magnuson, N. Gottardi-Littell, J. M. Lee, D. Yager, J. Crowley, K. Sambamurti, M. M. Rahman, A. B. Reiss, C. B. Eckman, B. Wolozin: Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem. 2004, 279, 34674-34681.
103. T. J. Nelson, D. L. Alkon: Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. J Biol Chem. 2005, 280, 7377-7387.
104. L. Puglielli, A. L. Friedlich, K. D. Setchell, S. Nagano, C. Opazo, R. A. Cherny, K. J. Barnham, J. D. Wade, S. Melov, D. M. Kovacs, A. L. Bush: Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. J Clin Invest. 2005, 115, 2556-2563.
105. I. Björkhem, S. Meaney: Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol. 2004, 24, 806-815.
106. W. J. Griffiths, Y. Wang. The importance of steroidomics in the study of neurodegenerative disease and ageing. Combinatorial Chemistry & High Throughput Screening. 2008, in press.
107. M. Axelson, J. Sjövall: Potential bile acid precursors in plasma-possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. J Steroid Biochem. 1990, 36, 631-640.
108. N. B. Javitt: Biologic role(s) of the 25(R),26-hydroxycholesterol metabolic pathway. Biochim Biophys Acta. 2000, 1529, 136-141.
109. J. L. Boyer: New concepts of mechanisms of hepatocyte bile formation. Physiol Rev. 1980, 60, 303-326.
110. J. Sjövall: On the concentration of bile acids in the human intestine during absorption. Bile acids and sterioids. Acta Physiol Scand. 1959, 46, 339-345.
111. A. Stiehl: Bile salt sulphates in cholestasis. Eur J Clin Invest. 1974, 4, 59-63.
112. B. Almé, J. Sjövall: Analysis of bile acid glucuronides in urine. Identification of 3 alpha, 6 alpha, 12 alpha-trihydroxy-5 betacholanoic acid. J Steroid Biochem. 1980, 13, 907-916.
113. S. Ikegawa, H. Okuyama, J. Oohashi, N. Murao, J. Goto: Separation and detection of bile acid 24-glucuronides in human urine by liquid chromatography combined with electrospray ionization mass spectrometry. Anal Sci. 1999, 15, 625-631.
114. H. U. Marschall, B. Egestad, H. Matern, S. Matern, J. Sjövall: Evidence for bile acid glucosides as normal constituents in human urine. FEBS Lett. 1987, 213, 411-414.
115. H. U. Marschall, G. Green, B. Egestad, J. Sjövall: Isolation of bile acid glucosides and N-acetylglucosaminides from human urine by ion-exchange chromatography and reversedphase high-performance liquid chromatography. J Chromatogr. 1988, 452, 459-468.
116. T. Goto, A. Shibata, D. Sasaki, N. Suzuki, T. Hishinuma, G. Kakiyama, T. Iida, N. Mano, J. Goto: Identification of a novel conjugate in human urine: bile acid acyl galactosides. Steroids. 2005, 70, 185-192.
117. Y. Yang, W. J. Griffiths, H. Nazer, J. Sjövall: Analysis of bile acids and bile alcohols in urine by capillary column liquid chromatography-mass spectrometry using fast atom bombardment or electrospray ionization and collision-induced dissociation. Biomed Chromatogr. 1997, 11, 240-255.
118. K. D. Setchell, J. M. Street: Inborn errors of bile acid synthesis. Semin Liver Dis. 1987, 7, 85-99.
119. B. G. Wolthers, M. Volmer, J. van der Molen, B. J. Koopman, A. E. de Jager, R. J. Waterreus: Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. Clin Chim Acta. 1983, 131, 53-65.
120. K. D. Setchell, J. E. Heubi: Defects in bile acid biosynthesis-diagnosis and treatment. J Pediatr Gastroenterol Nutr. 2006, 43 Suppl 1, S17-22.
121. C. R. Pullinger, C. Eng, G. Salen, S. Shefer, A. K. Batta, S. K. Erickson, A. Verhagen, C. R. Rivera, S. J. Mulvihill, M. J. Malloy, J. P. Kane: Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest. 2002, 110, 109-117.
122. K. D. Setchell, M. Schwarz, N. C. O'Connell, E. G. Lund, D. L. Davis, R. Lathe, H. R. Thompson, R. Weslie Tyson, R. J. Sokol, D. W. Russell: Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest. 1998, 102, 1690-703.
123. U. Mathis, G. Karlaganis, R. Preisig: Monohydroxy bile salt sulfates: tauro-3 beta-hydroxy-5-cholenoate-3-sulfate induces intrahepatic cholestasis in rats. Gastroenterology. 1983, 85, 674-681.
124. K. E. Bove, J. E. Heubi, W. F. Balistreri, K. D. Setchell: Bile acid synthetic defects and liver disease: a comprehensive review. Pediatr Dev Pathol. 2004, 7, 315-334.
125. W. J. Griffiths, C. Shackleton, J. Sjövall: Steroid Analysis In: The Encylopedia of Mass Spectrometry, Vol. 3. Eds. R. M. Capriolli, Elsevier, Oxford (UK) 2005, pp. 447-472.
126. I. Björkhem, D. Lütjohann, O. Breuer, A. Sakinis, A. Wennmalm: Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J Biol Chem. 1997, 272, 30178-30184.
127. D. Lütjohann, A. Brzezinka, E. Barth, D. Abramowski, M. Staufenbiel, K. von Bergmann, K. Beyreuther, G. Multhaup, T. A. Bayer: Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J Lipid Res. 2002, 43, 1078-1085.
128. D. Lütjohann, M. Stroick, T. Bertsch, S. Kühl, B. Lindenthal, K. Thelen, U. Andersson, I. Björkhem, Kv. K. Bergmann, K. Fassbender: High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids. 2004, 69, 431-438.
129. M. Heverin, N. Bogdanovic, D. Lütjohann, T. Bayer, I. Pikuleva, L. Bretillon, U. Diczfalusy, B. Winblad, I. Björkhem: Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res. 2004, 45, 186-193.
130. V. Leoni, T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, I. Björkhem: Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. J Lipid Res. 2003, 44, 793-799.
131. V. Leoni, D. Lütjohann, T. Masterman: Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J Lipid Res. 2005, 46, 191-195.
132. V. Leoni, M. Shafaati, A. Salomon, M. Kivipelto, I. Björkhem, L. O. Wahlund: Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? Neurosci Lett. 2006, 397, 83-87.
133. D. Lütjohann, A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli, R. D. Oehring, U. Schlegel, F. Jessen, M. L. Rao, K. von Bergmann, R. Heun: Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res. 2000, 41, 195-198.
134. N. Mast, R. Norcross, U. Andersson, M. Shou, K. Nakayama, I. Bjorkhem, I. A. Pikuleva: Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry. 2003, 42, 14284-14292.
135. J. B. Fenn, M. Mann, C. K. Meng, S. F. Wong, C. M. Whitehouse: Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989, 246, 64-71.
136. E. G. Lund, U. Diczfalusy: Quantitation of receptor ligands by mass spectrometry. Methods Enzymol. 2003, 364, 24-37.
137. X. Jiang, D. S. Ory, X. Han: Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. Rapid Commun Mass Spectrom. 2007, 21, 141-152.
138. W. J. Griffiths, S. Liu, G. Alvelius, J. Sjövall: Derivatisation for the characterisation of neutral oxosteroids by electrospray and matrix-assisted laser desorption/ionisation tandem mass spectrometry: the Girard P derivative. Rapid Commun Mass Spectrom. 2003, 17, 924-935.
139. C. H. Shackleton, H. Chuang, J. Kim, X. de la Torre, J. Segura: Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids. 1997, 62, 523-529.
140. C. J. Brooks, W. J. Cole, T. D. Lawrie, J. MacLachlan, J. H. Borthwick, G. M. Barrett: Selective reactions in the analytical characterisation of steroids by gas chromatography-mass spectrometry. J Steroid Biochem. 1983, 19, 189-201.
141. J. MacLachlan, A. T. Wotherspoon, R. O. Ansell, C. J. Brooks: Cholesterol oxidase: sources, physical properties and analytical applications. J Steroid Biochem Mol Biol. 2000, 72, 169-195.
142. Y. Wang, M. Hornshaw, G. Alvelius, K. Bodin, S. Liu, J. Sjövall, W. J. Griffiths: Matrix-assisted laser desorption/ionization high-energy collision-induced dissociation of steroids: analysis of oxysterols in rat brain. Anal Chem. 2006, 78, 164-173.
143. W. J. Griffiths, Y. Wang, G. Alvelius, S. Liu, K. Bodin, J. Sjövall: Analysis of oxysterols by electrospray tandem mass spectrometry. J Am Soc Mass Spectrom. 2006, 17, 341-362.
144. JI Teng, L. L. Smith: Sterol peroxidation by Pseudomonas fluorescens cholesterol oxidase. Steroids. 1996, 61, 627-633.
145. Y. Wang, W. J. Griffiths: Capillary liquid chromatography combined with tandem mass spectrometry for the study of neurosteroids and oxysterols in brain. Neurochem Int. 2008, 52, 506-521.
146. W. J. Griffiths, Y. Wang, K. Karu, E. Samuel, S. McDonnell, M. Hornshaw, C. Shackleton: Potential of Sterol Analysis by Liquid Chromatography-Tandem Mass Spectrometry for the Prenatal Diagnosis of Smith-Lemli-Opitz Syndrome. Clin Chem. 2008, 54, 1317-1324.
147. J. J. Palmgrén, A. Töyräs, T. Mauriala, J. Mönkkönen, S. Auriola: Quantitative determination of cholesterol, sitosterol, and sitostanol in cultured Caco-2 cells by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005, 821, 144-152.
148. Q. Tian, M. L. Failla, T. Bohn, S. J. Schwartz: High-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry determination of cholesterol uptake by Caco-2 cells. Rapid Commun Mass Spectrom. 2006, 20, 3056-3060.
149. A. Lövgren-Sandblom, M. Heverin, H. Larsson, E. Lundström, J. Wahren, U. Diczfalusy, I. Björkhem: Novel LC-MS/MS method for assay of 7alpha-hydroxy-4-cholesten-3-one in human plasma. Evidence for a significant extrahepatic metabolism. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 856, 15-19.
150. J. Lembcke, U. Ceglarek, G. M. Fiedler, S. Baumann, A. Leichtle, J. Thiery: Rapid quantification of free and esterified phytosterols in human serum using APPI-LC-MS/MS. J Lipid Res. 2005, 46, 21-26.
151. J. Sjövall, W. J. Griffiths, K. D. Setchell, N. Mano, J. Goto: Analysis of bile acids. In: Steroid Analysis 2nd Edition. Eds. H. L. Makin, D. B. Gower, Springer (Netherlands) 2008.
152. B. M. Warrack, G. C. DiDonato: Ion spray liquid chromatographic/mass spectrometric characterization of bile acids. Biol Mass Spectrom. 1993, 22, 101-111.
153. A. Roda, A. M. Gioacchini, C. Cerrè, M. Baraldini: High-performance liquid chromatographic-electrospray mass spectrometric analysis of bile acids in biological fluids. J Chromatogr B Biomed Appl. 1995, 665, 281-294.
154. S. Ikegawa, T. Yanagihara, N. Murao, H. Watanabe, J. Goto, T. Niwa: Separatory determination of bile acid 3-sulfates by liquid chromatography/ electrospray ionization mass spectrometry. J Mass Spectrom. 1997, 32, 401-407.
155. S. Ikegawa, N. Murao, T. Motoyama, T. Yanagihara, T. Niwa, J. Goto: Separation and detection of bile acid 3-glucuronides in human urine by liquid chromatography/electrospray ionization-mass spectrometry. Biomed Chromatogr. 1996, 10, 313-317.
156. T. Shinka, Y. Inoue, M. Ohse, T. Kuhara: Simple and quantitative analysis of urinary sulfated tauro- and glycodihydroxycholic acids in infant with cholestasis by electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 855, 104-108.
157. J. P. Hamilton, G. Xie, J. P. Raufman, S. Hogan, T. L. Griffin, C. A. Packard, D. A. Chatfield, L. R. Hagey, J. H. Steinbach, A. F. Hofmann: Human cecal bile acids: concentration and spectrum. Am J Physiol Gastrointest Liver Physiol. 2007, 293, G256-263.
158. N. Mano, T. Goto, M. Uchida, K. Nishimura, M. Ando, N. Kobayashi, J. Goto: Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain. J Lipid Res. 2004, 45, 295-300.
159. J. E. Evans, A. Ghosh, B. A. Evans, M. R. Natowicz: Screening techniques for the detection of inborn errors of bile acid metabolism by direct injection and micro-high performance liquid chromatography-continuous flow/fast atom bombardment mass spectrometry. Biol Mass Spectrom. 1993, 22, 331-337.
160. M. R. Natowicz, J. E. Evans: Abnormal bile acids in the Smith-Lemli-Opitz syndrome. Am J Med Genet. 1994, 50, 364-367.
161. I. Mushtaq, S. Logan, M. Morris, A. W. Johnson, A. M. Wade, D. Kelly, P. T. Clayton: Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. BMJ. 1999, 319, 471-47. Erratum in: BMJ 1999, 319, 1253.
162. S. Perwaiz, B. Tuchweber, D. Mignault, T. Gilat, I. M. Yousef: Determination of bile acids in biological fluids by liquid chromatography- electrospray tandem mass spectrometry. J Lipid Res. 2001, 42, 114-119.
163. I. Burkard, A. von Eckardstein, K. M. Rentsch: Differentiated quantification of human bile acids in serum by highperformance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005, 826, 147-159.
164. F. P. Martin, M. E. Dumas, Y. Wang, C. Legido-Quigley, I. K. Yap, H. Tang, S. Zirah, G. M. Murphy, O. Cloarec, J. C. Lindon, N. Sprenger, L. B. Fay, S. Kochhar, P. van Bladeren, E. Holmes, J. K. Nicholson: A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol. 2007, 3, 112.
165. B. Ruan, W. K. Wilson, J. Pang, N. Gerst, F. D. Pinkerton, J. Tsai, R. I. Kelley, F. G. Whitby, D. M. Milewicz, J. Garbern, G. J. Schroepfer Jr: Sterols in blood of normal and Smith-Lemli-Opitz subjects. J Lipid Res. 2001, 42, 799-812.
166. H. C. Andersson, L. Kratz, R. Kelley: Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay. Am J Med Genet. 2002, 113, 315-319.
167. J. Dorszewska, Z. Adamczewska-Goncerzewicz: Patterns of free and esterified sterol fractions of the cerebral white matter in severe and moderate experimental hypoxia. Med Sci Monit. 2000, 6, 227-231.
168. M. Wender, Z. Adamczewska-Goncerzewicz, J. Doroszewska: Transformation of sterols pattern in course of late development of rat brain. Folia Neuropathol. 1995, 33, 31-34.
169. D. Lütjohann: Cholesterol metabolism in the brain: importance of 24S-hydroxylation. Acta Neurol Scand Suppl. 2006, 185, 33-42.
170. C. Shackleton: Genetic disorders of steroid metabolism diagnosed by mass spectrometry. In Laboratory Guide to the Methods in Biochemical Genetics. Eds. N. Blau, M. Duran, K. M. Gibson, Springer, Heidelberg (Germany) 2008.
171. S. Liu, J. Sjövall, W. J. Griffiths: Neurosteroids in rat brain: extraction, isolation, and analysis by nanoscale liquid chromatography- electrospray mass spectrometry. Anal Chem. 2003, 75, 5835-5846.
172. H. Miyajima, J. Adachi, S. Kohno, Y. Takahashi, Y. Ueno, T. Naito: Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaeruloplasminaemia patients. QJM. 2001, 94, 417-422.
173. S. Meaney. Ph. D. Thesis, Karolinska Institute, Stockholm (Sweden) 2003.
174. Y. Y. Lin, M. Welch, S. Lieberman: The detection of 20S- hydroxycholesterol in extracts of rat brains and human placenta by a gas chromatograph/mass spectrometry technique. J Steroid Biochem Mol Biol. 2003, 85, 57-61.
175. Z. X. Yao, R. C. Brown, G. Teper, J. Greeson, V. Papadopoulos: 22R-Hydroxycholesterol protects neuronal cells from beta-amyloid-induced cytotoxicity by binding to beta-amyloid peptide. J Neurochem. 2002, 83, 1110-1119